Literature DB >> 10799901

IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii.

Y Suzuki1, A Sher, G Yap, D Park, L E Neyer, O Liesenfeld, M Fort, H Kang, E Gufwoli.   

Abstract

The role for IL-10 in the immunopathogenesis of acute toxoplasmosis following peroral infection was examined in both genetically susceptible C57BL/6 and resistant BALB/c mice. C57BL/6-background IL-10-targeted mutant (IL-10-/-) mice all died in 2 wk after infection with 20 cysts of the ME49 strain, whereas only 20% of control mice succumbed. Histological studies revealed necrosis in the small and large intestines and livers of infected IL-10-/- mice. The necrosis in the small intestine was the most severe pathologic response and was not observed in control mice. Treatment of infected IL-10-/- mice with either anti-CD4 or anti-IFN-gamma mAb prevented intestinal pathology and significantly prolonged time to death. Treatment of these animals with anti-IL-12 mAb also prevented the pathology. Significantly greater amounts of IFN-gamma mRNA were detected in the lamina propria lymphocytes obtained from the small intestine of infected IL-10-/- mice than those from infected control mice. In common with C57BL/6-background IL-10-/- mice, BALB/c-background IL-10-/- mice all died developing intestinal pathology after infection. Control BALB/c mice all survived even after infection with 100 cysts and did not develop the intestinal lesions. Treatment with anti-IFN-gamma mAb prevented the pathology and prolonged time to death of the infected IL-10-/- mice. These results strongly suggest that IL-10 plays a critical role in down-regulating IFN-gamma production in the small intestine following sublethal peroral infection with Toxoplasma gondii and that this down-regulatory effect of IL-10 is required for prevention of development of IFN-gamma-mediated intestinal pathology and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799901     DOI: 10.4049/jimmunol.164.10.5375

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  87 in total

Review 1.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 2.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

3.  Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18.

Authors:  D Struck; I Frank; S Enders; U Steinhoff; C Schmidt; A Stallmach; O Liesenfeld; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 4.  Modeling the T cell immune response: a fascinating challenge.

Authors:  Penelope A Morel; James R Faeder; William F Hawse; Natasa Miskov-Zivanov
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-26       Impact factor: 2.745

Review 5.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

Review 6.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

7.  Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Authors:  Michelle N Kelly; Jay K Kolls; Kyle Happel; Joseph D Schwartzman; Paul Schwarzenberger; Crescent Combe; Magali Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors.

Authors:  J Diana; C Vincent; F Peyron; S Picot; D Schmitt; F Persat
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

9.  Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells.

Authors:  Georgia Perona-Wright; Katja Mohrs; Frank M Szaba; Lawrence W Kummer; Rajat Madan; Christopher L Karp; Lawrence L Johnson; Stephen T Smiley; Markus Mohrs
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

10.  Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection.

Authors:  Kevin N Couper; Paula A Lanthier; Georgia Perona-Wright; Lawrence W Kummer; Wangxue Chen; Stephen T Smiley; Markus Mohrs; Lawrence L Johnson
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.